Tag: CERo Therapeutics Holdings
CERo Therapeutics ($CERO) Advances AML Treatment with FDA Orphan Drug Status
CERo Therapeutics Holdings, Inc. (CERO) has received Orphan Drug Designation from the U.S. Food and Drug Administration for its lead drug candidate CER-1236, targeting...